CisplatinAntineoplastic Combined Chemotherapy ProtocolsInduction ChemotherapyChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsMetoclopramideOndansetronTreatment OutcomeVomitingEtoposideDisease-Free SurvivalDiphenhydramineDrug Administration ScheduleAntiemeticsPaclitaxelSurvival AnalysisNeoplasm StagingDeoxycytidineNauseaRemission InductionSurvival RateCarcinoma, Squamous CellCyclophosphamideDoxorubicinTesticular NeoplasmsGranisetronNeoadjuvant TherapyNeoplasms, Germ Cell and EmbryonalLung NeoplasmsCarboplatinTaxoidsHead and Neck NeoplasmsCytarabineIfosfamidePrognosisVinblastineLeukemia, Myeloid, AcuteDaunorubicinCarcinoma, Non-Small-Cell LungFluorouracilMethotrexateBreast NeoplasmsRadiotherapy, AdjuvantBleomycinNeoplasm Recurrence, LocalDrug Resistance, NeoplasmRadiotherapyVincristineSalvage TherapyNeutropeniaPrecursor Cell Lymphoblastic Leukemia-LymphomaAntimetabolites, AntineoplasticFollow-Up StudiesRadiotherapy DosageTransplantation, AutologousChemoradiotherapyTime FactorsEnzyme InductionKaplan-Meier EstimateIdarubicinDose-Response Relationship, DrugGranulocyte Colony-Stimulating FactorHypopharyngeal NeoplasmsLaryngectomyMelphalanNasopharyngeal NeoplasmsAdenocarcinomaLeukemia, MyeloidVindesineOvarian NeoplasmsProspective StudiesNeoplasm MetastasisLeukopeniaOrganoplatinum CompoundsCamptothecinAntineoplastic Agents, PhytogenicAnthracyclinesPlatinumGerminomaInfusions, IntravenousNeoplasmsMitoxantroneHematopoietic Stem Cell TransplantationCell Line, TumorMucositisDose FractionationCranial IrradiationThiotepaAntibiotics, AntineoplasticLymphoma, Non-HodgkinAsparaginaseRecurrenceClinical Trials as TopicLaryngeal NeoplasmsBone NeoplasmsAntineoplastic Agents, AlkylatingMesnaThrombocytopeniaFeasibility Studies